SIK2 and pulmonary fibrosis: Inhibition of SIK2 significantly attenuated bleomycin-induced pulmonary fibrosis by promoting dephosphorylation and nuclear translocation of CRTC2 and consequently activating the CREB anti-fibrotic pathway.